понедельник, 12 сентября 2011 г.

12 Million Euros From The European Commission For 'RUBICON'

The European Commission in Brussels has awarded a 12 Million Euro
grant to foster the collaboration of European experts in the field of
Ubiquitin research.


The Ubiquitin system plays a crucial role in
important cellular processes such as the removal of proteins no longer
required or insufficiently constructed, the regulation of the cell cycle,
immune response, and the repair of DNA.


When this system is
defective, it can lead to infectious and inflammatory diseases, cancer,
and neurodegenerative disorders such as Alzheimer`s and Parkinson`s
disease.


A consortium of 15 leading research laboratories in Europe
and Israel, among them the Max Delbrьck-Center for Molecular
Medicine (MDC) Berlin-Buch, Germany, and five small and medium
enterprises have initiated this research project entitled the "Role of
Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation", or
RUBICON for short. Prof. Maria Masucci, Karolinska Institutet,
Stockholm, Sweden, will serve as the coordinator of the Network.


Max Delbrьck Center for Molecular Medicine(MDC) Berlin-Buch

Robert-Rцssle-Str. 10; D-13125 Berlin

Germany


mdc-berlin.de/englisch


Further Information:

rubicon-net

Buy Diflucan Without Prescription

Комментариев нет:

Отправить комментарий